| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 09/02/2008 | US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 09/02/2008 | US7420079 Intermediates for making 1(alpha-amino-1-(cyclopropyl-fused pyrrolidinylcarbonyl)methyl)-3-hydroxyadamantanes, e.g., methyl 3-hydroxy-<a-oxotricyclo[3.3.1.13,7]decane-1-acetate |
| 09/02/2008 | US7420078 Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7420002 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues |
| 09/02/2008 | US7419999 Gamma lactams as prostaglandin agonists and use thereof |
| 09/02/2008 | US7419980 Treating conditions improved by monoamine reuptake; 1-[1-(2-naphthyl)-2-piperazin-1-ylethyl]cyclobutanol; sexual disorders, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, hot flashes |
| 09/02/2008 | US7419975 Organic compounds |
| 09/02/2008 | US7419936 Optically active 2,5-bisaryl-Δ1-pyrrolines and their use as pest control agents |
| 09/02/2008 | CA2350609C N-substituted 2-cyanopyrrolidines |
| 09/02/2008 | CA2289911C Polyalkylene succinimides and post-treated derivatives thereof |
| 09/02/2008 | CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 08/28/2008 | WO2008103613A2 Hydroxylamine compounds and methods of their use |
| 08/28/2008 | WO2008103426A1 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 08/28/2008 | WO2008101953A1 Compounds of formula (i) as serine protease inhibitors |
| 08/28/2008 | WO2008101914A2 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 08/28/2008 | WO2008101515A1 New synthons for the synthesis of chiral peptide nucleic acids and methods for preparing the same |
| 08/28/2008 | WO2008083967A3 Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid |
| 08/28/2008 | WO2008070305A3 1, 5-diphenyl-3-pyridinylamino-1, 5-dihydropyrrolidin-2-one as cbl' receptor modulator |
| 08/28/2008 | US20080207921 purified polylactic acid or glycolic acid-lactic acid copolymer; insert for drugs |
| 08/28/2008 | US20080207908 Processes for the preparation of piperidinyl-substituted urea compounds |
| 08/28/2008 | US20080207736 Chronic obstructive pulmonary diseases; asthma |
| 08/28/2008 | US20080207735 1-Amino Linked Compounds |
| 08/28/2008 | US20080207734 Novel alkoxylactones, alkoxylactams and alkoxythiolactams for controlling processes based on microbial interaction |
| 08/28/2008 | US20080207686 Antibiotics |
| 08/28/2008 | US20080206820 activated ester of the carboxyl-containing compound (carboxylic acid) is reacted with H217O or H218O in the presence of an activator; labelled amino acid |
| 08/28/2008 | US20080206812 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles |
| 08/28/2008 | CA2679066A1 Hydroxylamine compounds and methods of their use |
| 08/28/2008 | CA2678146A1 Compounds of formula (i) as serine protease inhibitors |
| 08/28/2008 | CA2675669A1 Novel compounds |
| 08/27/2008 | EP1961742A1 compounds of formula (I) as serine protease inhibitors |
| 08/27/2008 | EP1960379A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides |
| 08/27/2008 | EP1697318B1 Prolinylarylacetamides |
| 08/27/2008 | CN101250152A Method for preparing 1,3-di(2,4-dimaleoyl imino phenoxy) benzene |
| 08/27/2008 | CN101250151A Method for preparing 2,2-di(3-maleoyl imino-4-(4-nitryl phenoxy) phenyl] propane |
| 08/27/2008 | CN101250150A Method for preparing 3,3'-dimaleoyl imino-4,4'-di(4-nitrophenoxy) biphenyl |
| 08/27/2008 | CN101250149A Method for preparing 4,4-di(3-dimaleoyl imino-4-(4-cyano phenoxy) triphenylmethane |
| 08/27/2008 | CN101249433A Rare-earth metal oxide/zircite process for preparation of catalysts |
| 08/27/2008 | CN100413844C Multiple photon absorptive phenyl fluorene derivative and its preparing method |
| 08/26/2008 | US7417058 Reacting cyanophenyl-4-sulfonylchloride with a piperidine-4-oxo in presence of ethylene glycol to form an intermediate, reducing cyano group, followed by amidation, then reacting with an amine to form sulfonamide end |
| 08/26/2008 | US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole |
| 08/26/2008 | US7417006 Such as triethylammonium salt of N-[tris(2,3,4,5,6-pentafluorophenyl)borane]indole; metallocene cocatalysts; effective at low concentration; low cost synthesis |
| 08/26/2008 | CA2532743C Intermediates for preparing dialkyl-halogenophenyl-substituted ketoenols |
| 08/26/2008 | CA2392165C Vitamin d analogues |
| 08/21/2008 | WO2008100651A2 Preparation of darifenacin and its salts |
| 08/21/2008 | WO2008099221A1 Amide and urea derivatives for the treatment of metabolic diseases |
| 08/21/2008 | WO2008098887A1 Catalytic method for producing (meth)acrylic acid esters of n-hydroxyalkylated lactams |
| 08/21/2008 | WO2008098885A1 Method for producing (meth)acrylic esters of n-hydroxyalkylated lactams |
| 08/21/2008 | WO2008098798A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents |
| 08/21/2008 | WO2008098368A1 Inhibitors of hepatitis c ns3 protease |
| 08/21/2008 | WO2008053393A8 Rotary actuator |
| 08/21/2008 | WO2008053312A8 Process for preparing amorphous atorvastatin hemi calcium salt and its intermediate |
| 08/21/2008 | WO2008024978A3 Tetrahydroindolone and tetrahydroindazolone derivatives |
| 08/21/2008 | US20080200695 Complex catalyst which contains noval ligand system and transition metal |
| 08/21/2008 | US20080200652 Immunoglobulin fusion for use as diagnostic sensor and drug screening tool |
| 08/21/2008 | US20080200551 Flourene Derivative |
| 08/21/2008 | US20080200533 Creating modified complex molecules having reduced toxicity and enhanced bioavailability; such as reaction product of atorvastatin and 2,6-diaminohexanoic acid; increasing solubility; reducing dosage levels |
| 08/21/2008 | US20080200511 Novel Compounds and Methods of Using the Same |
| 08/21/2008 | US20080200466 Organic Compounds For the Treatment of Inflammatory or Allergic Conditions |
| 08/21/2008 | US20080200465 Antipathogenic benzamide compounds |
| 08/21/2008 | CA2676297A1 Inhibitors of hepatitis c ns3 protease |
| 08/20/2008 | EP1958934A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents |
| 08/20/2008 | EP1957485A2 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 08/20/2008 | EP1957452A1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium |
| 08/20/2008 | EP1957451A1 Soft anticholinergic zwitterions |
| 08/20/2008 | EP1957450A1 Serotonin transporter (sert) inhibitors |
| 08/20/2008 | EP1957449A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 08/20/2008 | EP1957448A1 Substituted azacycloalkanes useful for treating cns conditions |
| 08/20/2008 | EP1957441A2 Intermediate compounds for the preparation of statins |
| 08/20/2008 | EP1957111A2 Method for the production of a keratin-binding effector molecule |
| 08/20/2008 | EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 08/20/2008 | EP1956909A1 Microbiocides |
| 08/20/2008 | EP1956907A2 Cyanobenzene compounds for combating animal pests |
| 08/20/2008 | EP1685102A4 Melanocortin receptor agonists |
| 08/20/2008 | EP1569647B1 Cyclohexyl compounds as ccr5 antagonists |
| 08/20/2008 | EP1428530B1 Tetrapeptide derivative crystals |
| 08/20/2008 | EP1249233B1 Npyy5 antagonists |
| 08/20/2008 | CN101248069A Androgen receptor modulators and method of treating disease using the same |
| 08/20/2008 | CN101248062A C-fms kinase inhibitors |
| 08/20/2008 | CN101248042A Sulfonamide compounds and uses thereof |
| 08/20/2008 | CN101245043A Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 08/19/2008 | US7414145 nucleophilic addition reaction of enamide compound accompanied by hydroxyl ( OH) formation to carbonyl is carried out in the presence of a chiral catalyst with copper or nickel |
| 08/19/2008 | US7414142 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators |
| 08/19/2008 | US7414141 Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin |
| 08/19/2008 | US7414071 Such as 5-(3-(2S-(3R-hydroxy-4-(3-trifluoromethyl-phenyl)-butyl)-5-oxo-pyrrolidin-1 -yl)-propyl)-thiophene-2-carboxylic acid; prostaglandin E2 agonists subtypes (EP4); for treatment of (ocular) hypertension, liver failure, and glaucoma |
| 08/19/2008 | US7414064 Pesticides for crops; agriculture, horticulture |
| 08/14/2008 | WO2008097225A1 Maleimide containing ester and sulfide functionalities |
| 08/14/2008 | WO2008096841A1 Dimerized cyclo derivative |
| 08/14/2008 | WO2008062446A3 An extended release composition of levetiracetam, which exhibits no adverse food effect |
| 08/14/2008 | WO2008033475A3 Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions |
| 08/14/2008 | US20080194841 Preparation of Optically Pure Beta-Amino Acids Having Affinity for the Alpha-Delta Protein |
| 08/14/2008 | US20080194840 Process for Preparing Levetiracetam and Racemization of (R)- and (S)-2-Amino Butynamide and the Corresponding Acid Derivatives |
| 08/14/2008 | US20080194697 ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane, used for treating prostate cancer, prostatitis and benign prostatic hyperplasia |
| 08/14/2008 | US20080194633 E.g., [(1-(2-aminoacetyl)-4-{N-[(3-fluoro-2-methylphenyl)methyl]carbamoyl}(4-piperidyl))methoxy]-N-(4-ethylphenyl)carboxamide; smooth muscle myosin or non-muscle myosin modulator; hypotensive agent; asthma, COPD, bronchoconstrictive disease, glaucoma, pre-menstrual cramps, erectile dysfunction |
| 08/14/2008 | US20080194581 Pyrrole derivatives, intermediates therefor, preparation and therapeutic use thereof |
| 08/14/2008 | US20080194549 Organic Compounds |
| 08/14/2008 | US20080194537 Tetrapeptide capable of inhibiting binding of the Smac protein to Inhibitors of apoptosis, thus promoting apoptosis or sensitizing cells; antiproliferative and anticarcinogenic agents |
| 08/14/2008 | US20080194536 Cyanoarylamines |
| 08/14/2008 | US20080193574 Central nervous system disorders;Alzheimer's disease; using ginger oil |
| 08/14/2008 | US20080193411 Anti-viral Compounds |